{"transactions":[{"id":700622,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27752,"kind":"person","name":"Selhorn Ryan J","position":1,"cik":"0001670673","reported_name":"Selhorn Ryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-30T20:33:22.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock, which vest as follows: 1/3 on July 28, 2027, with the remaining restricted stock vesting in 8 equal quarterly installments beginning October 28, 2027."}],"balance_after":74743,"source":{"system":"sec-edgar","filing":"0001437749-26-025080","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670673/000143774926025080/rdgdoc.xml","form_type":"4"}},{"id":1022211,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27752,"kind":"person","name":"Selhorn Ryan J","position":1,"cik":"0001670673","reported_name":"Selhorn Ryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:12:18.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027."}],"balance_after":49743,"source":{"system":"sec-edgar","filing":"0001437749-25-030645","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670673/000143774925030645/rdgdoc.xml","form_type":"4"}},{"id":1022210,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27752,"kind":"person","name":"Selhorn Ryan J","position":1,"cik":"0001670673","reported_name":"Selhorn Ryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:12:18.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":16243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted fully vested restricted stock in lieu of cash in satisfaction of their annual bonus."}],"balance_after":32243,"source":{"system":"sec-edgar","filing":"0001437749-25-030645","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670673/000143774925030645/rdgdoc.xml","form_type":"4"}},{"id":1235809,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27752,"kind":"person","name":"Selhorn Ryan J","position":1,"cik":"0001670673","reported_name":"Selhorn Ryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T00:22:47.000Z","date":"2025-02-05","kind":"exercise","planned":false,"acquired":false,"shares":105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock.  The RSUs were granted February 5, 2022, vesting quarterly beginning February 5, 2023, and ending February 5, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock units (RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock.  The RSUs were granted February 5, 2022, vesting quarterly beginning February 5, 2023, and ending February 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted stock units (RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock.  The RSUs were granted February 5, 2022, vesting quarterly beginning February 5, 2023, and ending February 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":105},"source":{"system":"sec-edgar","filing":"0000912282-25-000223","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670673/000091228225000223/form4.xml","form_type":"4"}},{"id":1235808,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27752,"kind":"person","name":"Selhorn Ryan J","position":1,"cik":"0001670673","reported_name":"Selhorn Ryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-03-04T00:22:47.000Z","date":"2025-02-05","kind":"exercise","planned":false,"acquired":true,"shares":105,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock.  The RSUs were granted February 5, 2022, vesting quarterly beginning February 5, 2023, and ending February 5, 2025."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0000912282-25-000223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670673/000091228225000223/form4.xml","form_type":"4"}},{"id":1366562,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27752,"kind":"person","name":"Selhorn Ryan J","position":1,"cik":"0001670673","reported_name":"Selhorn Ryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-11-13T21:10:22.000Z","date":"2024-11-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock which vest as follows:  One-third on November 11, 2025; 1/12th of the original grant quarterly thereafter through November 11, 2027."}],"balance_after":15895,"source":{"system":"sec-edgar","filing":"0000912282-24-000798","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670673/000091228224000798/form4.xml","form_type":"4"}}]}